Marker Therapeutics (MRKR) Share-based Compensation (IS) (2012 - 2014)
Marker Therapeutics (MRKR) reported Share-based Compensation (IS) of $686250.0 for Q1 2014, up 911.99% year-over-year from $67812.0 in Q1 2013, and up 911.99% quarter-over-quarter from $67812.0 in Q1 2013.
Marker Therapeutics (MRKR) Share-based Compensation (IS) (2012 - 2014) Analysis & Trends
Marker Therapeutics (MRKR) has 3 years of Share-based Compensation (IS) data on file, last reported at $686250.0 in Q1 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 1.45 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 892,057.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 14.90 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Marker Therapeutics | 28.20 Mn | 28.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2014 | 686,250.00 |
| Mar 31, 2014 | 686,250.00 |
| Mar 31, 2013 | 67,812.00 |
| Mar 31, 2013 | 67,812.00 |
| Mar 31, 2012 | 133,908.00 |
| Mar 31, 2012 | 133,908.00 |